Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis
@article{Farris2017PharmacodynamicsOC, title={Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis}, author={M. Farris and C. Bastianelli and Elena Rosato and I. Brosens and G. Benagiano}, journal={Expert Review of Clinical Pharmacology}, year={2017}, volume={10}, pages={1129 - 1144} }
ABSTRACT Introduction: The pharmacodynamic effects of various combined oral estrogen-progestin combinations (COC) are examined for their components alone or in the various combined formulations. Special emphasis is given to products containing natural estrogens. Areas covered: Recent information on the effect of androgens, estrogens, progestins, as well as various COC combinations on the coagulation cascade will be reviewed aiming at providing an updated picture. The present article reviews… CONTINUE READING
Topics from this paper
13 Citations
Pharmacodynamics of combined estrogen–progestin oral contraceptives: 4. Effects on uterine and cervical epithelia
- Medicine
- Expert review of clinical pharmacology
- 2020
- 1
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
- Medicine
- Contraception
- 2020
- 1
Effects of low-dose combined oral contraceptives and protein S K196E mutation on anticoagulation factors: a prospective observational study
- Medicine
- International Journal of Hematology
- 2019
- 4
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk.
- Medicine
- Seminars in thrombosis and hemostasis
- 2020
A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy.
- Medicine
- Expert opinion on drug safety
- 2020
Blood Hormones and Venous Thromboembolic Events: Lack of Association or Lack of Standardization?
- Medicine
- Thrombosis and haemostasis
- 2018
- PDF
Mercury induces nuclear estrogen receptors to act as vasoconstrictors promoting endothelial denudation via the PI3K/Akt signaling pathway.
- Chemistry, Medicine
- Toxicology and applied pharmacology
- 2019
- 1
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
- Medicine
- Hamostaseologie
- 2020
- 2
- PDF
Contraception for the Cardiac Patient: a Cardiologist’s Primer
- Medicine
- Current Treatment Options in Cardiovascular Medicine
- 2020
- PDF
Disorders of Puberty: Pharmacotherapeutic Strategies for Management.
- Medicine
- Handbook of experimental pharmacology
- 2019
- 5
References
SHOWING 1-10 OF 213 REFERENCES
Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism
- Medicine
- Expert review of clinical pharmacology
- 2017
- 8
Effect of oral contraceptives on haemostasis variables.
- Medicine
- Thrombosis and haemostasis
- 1997
- 175
- Highly Influential
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
- Medicine
- American journal of obstetrics and gynecology
- 1990
- 89
Coagulation effects of oral contraception.
- Medicine
- American journal of obstetrics and gynecology
- 1987
- 142
- Highly Influential
Estradiol valerate and dienogest: a new approach to oral contraception
- Medicine
- International journal of women's health
- 2011
- 16
- PDF